$164.60
-1.23 (-0.74%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+495.51%
YTD
+408.18%
Open$165.83
Previous Close$165.83
Day High$170.66
Day Low$162.86
52W High$163.70
52W Low$23.30
Volume—
Avg Volume1.69M
Market Cap9.42B
P/E Ratio—
EPS$-2.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$39.72
Above
SMA 200
$33.17
Above
RSI (14)
70
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-56.5% upside
Current
$164.60
$164.60
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 381.22M | 310.57M | 1.46B |
| Net Income | -78,632,002 | -57,652,791 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -63,331,850 | -49,014,466 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |